Identification of a novel secretogranin II-derived peptide (SgII(187-252)) in adult and fetal human adrenal glands using antibodies raised against the human recombinant peptide.

Molecular cloning of secretogranin II (SgII) in phylogenetically distant species has recently revealed the existence of a highly conserved 66-amino acid peptide flanked by preserved pairs of basic residues. This observation suggested that this peptide, named EM66, which had not been described to date, could be an important processing product of SgII. The aim of the present study was to investigate the possible occurrence of EM66 in the human adrenal gland. The EM66 peptide was generated in Escherichia coli, which was programmed to make a fusion protein containing the human EM66 sequence. The affinity-purified fusion protein was used to raise polyclonal antibodies in rabbits. The free EM66 peptide was obtained by cleavage of the fusion protein followed by high performance liquid chromatography purification. Immunohistochemical analysis using the EM66 antibodies revealed intense labeling of adrenochromaffin cells in the adult adrenal medulla and the fetal adrenal gland. A sensitive and specific RIA was developed and applied to the detection of EM66-like immunoreactivity in extracts of adult adrenal medulla and whole fetal adrenal gland after high performance liquid chromatographic analysis. A major immunoreactive species exhibiting the same retention time as recombinant EM66 was detected in both adult and fetal adrenal extracts. Taken together, these data demonstrate that posttranslational processing of SgII actually generates EM66 in the adrenal gland. The strong conservation of the amino acid sequence of EM66 in the vertebrate phylum and the occurrence of the mature peptide in both fetal and adult chromaffin cells suggest that EM66 could play an important physiological role in the human adrenal gland.

[1]  J. Marksteiner,et al.  Ontogenic development of secretogranin II and of its processing to secretoneurin in rat brain. , 1997, Brain research. Developmental brain research.

[2]  P. Pévet,et al.  Secretoneurin: a new neuropeptide in the rodent pineal gland , 1997, Cell and Tissue Research.

[3]  R. Kirchmair,et al.  Inhibition of proliferation and stimulation of migration of endothelial cells by secretoneurin in vitro. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[4]  A. Smit,et al.  Identification of a Molluscan Homologue of the Neuroendocrine Polypeptide 7B2* , 1997, The Journal of Biological Chemistry.

[5]  G. Nussdorfer.  Paracrine control of adrenal cortical function by medullary chromaffin cells. , 1996, Pharmacological reviews.

[6]  H. Vaudry,et al.  Molecular cloning of frog secretogranin II reveals the occurrence of several highly conserved potential regulatory peptides , 1996, FEBS letters.

[7]  G. Martens,et al.  The Neuroendocrine Proteins Secretogranin II and III Are Regionally Conserved and Coordinately Expressed with Proopiomelanocortin in Xenopus Intermediate Pituitary , 1996, Journal of neurochemistry.

[8]  C. Wiedermann,et al.  Stimulation of human skin fibroblast migration by the neuropeptide secretoneurin. , 1996, European journal of pharmacology.

[9]  W. Huttner,et al.  Chromogranin B (secretogranin I) promotes sorting to the regulated secretory pathway of processing intermediates derived from a peptide hormone precursor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Fischer‐Colbrie,et al.  Secretogranin II: Relative Amounts and Processing to Secretoneurin in Various Rat Tissues , 1996, Journal of neurochemistry.

[11]  C. Sumners,et al.  Regulation of secretogranin II mRNA in rat neuronal cultures. , 1995, Brain research. Molecular brain research.

[12]  D. Steiner,et al.  Proteolytic Processing Mechanisms in the Biosynthesis of Neuroendocrine Peptides: The Subtilisin-like Proprotein Convertases , 1995, Frontiers in Neuroendocrinology.

[13]  S. Tooze,et al.  Characterization of the endopeptidase PC2 activity towards secretogranin II in stably transfected PC12 cells. , 1995, The Biochemical journal.

[14]  L. Eiden,et al.  Chromogranin A: current status as a precursor for bioactive peptides and a granulogenic/sorting factor in the regulated secretory pathway , 1995, Regulatory Peptides.

[15]  E. Agneter,et al.  Sustained Dopamine Release Induced by Secretoneurin in the Striatum of the Rat: A Microdialysis Study , 1995, Journal of neurochemistry.

[16]  L. Muller,et al.  Production and secretion of N-terminal secretogranin II derived peptides in GH3B6 prolactin cells , 1995, Molecular and Cellular Endocrinology.

[17]  B. Griffond,et al.  Early detection of secretogranin-II (SgII) in the human fetal pituitary: immunocytochemical study using an antiserum raised against a human recombinant SgII. , 1995, Endocrinology.

[18]  A. Laslop,et al.  Secretogranin II: Molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin , 1995, Progress in Neurobiology.

[19]  N. Seidah,et al.  Processing of secretogranin II by prohormone convertases: Importance ofPC1 in generation of secretoneurin , 1995, FEBS letters.

[20]  G. Martens,et al.  7B2 is a neuroendocrine chaperone that transiently interacts with prohormone convertase PC2 in the secretory pathway , 1994, Cell.

[21]  Y. Anouar,et al.  Identification of a TPA-responsive element mediating preferential transactivation of the galanin gene promoter in chromaffin cells. , 1994, The Journal of biological chemistry.

[22]  H. Gerdes,et al.  The granin protein family: Markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors , 1994, Journal of endocrinological investigation.

[23]  R. Kirchmair,et al.  Attraction of human monocytes by the neuropeptide secretoneurin , 1993, FEBS letters.

[24]  M. Feuilloley,et al.  Localization, characterization and activity of pituitary adenylate cyclase-activating polypeptide in the frog adrenal gland. , 1993, The Journal of endocrinology.

[25]  M. Tötsch,et al.  Chromogranin A, secretogranin II and vasoactive intestinal peptide in phaeochromocytomas and ganglioneuromas , 1993, Histopathology.

[26]  R. Kirchmair,et al.  Secretoneurin—a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C) , 1993, Neuroscience.

[27]  W. Huttner,et al.  The organisation of the mouse secretogranin II gene , 1992, FEBS letters.

[28]  R. Fischer‐Colbrie,et al.  The chromogranins A and B: The first 25 years and future perspectives , 1992, Neuroscience.

[29]  W. Huttner,et al.  Milieu-induced, selective aggregation of regulated secretory proteins in the trans-Golgi network , 1991, The Journal of cell biology.

[30]  Y. Anouar,et al.  Estradiol negatively regulates secretogranin II and chromogranin A messenger ribonucleic acid levels in the female rat pituitary but not in the adrenal. , 1991, Endocrinology.

[31]  H. Vaudry,et al.  Identification of a peptide arising from the specific post‐translation processing of secretogranin II , 1991, FEBS letters.

[32]  Y. Anouar,et al.  Differential expression of secretogranin II and chromogranin A genes in the female rat pituitary through sexual maturation and estrous cycle. , 1991, Endocrinology.

[33]  L. Eiden,et al.  Sequence analysis, tissue distribution and regulation by cell depolarization, and second messengers of bovine secretogranin II (chromogranin C) mRNA. , 1990, The Journal of biological chemistry.

[34]  P. Argos,et al.  The primary structure of human secretogranin II, a widespread tyrosine-sulfated secretory granule protein that exhibits low pH- and calcium-induced aggregation. , 1989, The Journal of biological chemistry.

[35]  W. Huttner,et al.  The primary structure of rat secretogranin II deduced from a cDNA sequence. , 1988, Nucleic acids research.

[36]  R. Fischer‐Colbrie,et al.  Isolation and Characterization of Chromogranins A, B, and C from Bovine Chromaffin Granules and a Rat Pheochromocytoma , 1987, Journal of neurochemistry.

[37]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[38]  W. Huttner,et al.  Synaptophysin and chromogranins/secretogranins widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis , 1989, Virchows Archiv. B, Cell pathology including molecular pathology.

[39]  G. Streeter.  Weight, sitting height, head size, foot length, and menstrual age of the human embryos , 1920 .